136 related articles for article (PubMed ID: 32237978)
1. Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver.
Guo FF; Xiao M; Wang SY; Zeng T; Cheng L; Xie Q
Toxicol Mech Methods; 2020 Jul; 30(6):407-416. PubMed ID: 32237978
[TBL] [Abstract][Full Text] [Related]
2. Chronic alcohol-induced liver injury and oxidant stress are decreased in cytochrome P4502E1 knockout mice and restored in humanized cytochrome P4502E1 knock-in mice.
Lu Y; Wu D; Wang X; Ward SC; Cederbaum AI
Free Radic Biol Med; 2010 Nov; 49(9):1406-16. PubMed ID: 20692331
[TBL] [Abstract][Full Text] [Related]
3. Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver.
Zeng T; Zhang CL; Zhao N; Guan MJ; Xiao M; Yang R; Zhao XL; Yu LH; Zhu ZP; Xie KQ
Redox Biol; 2018 Apr; 14():295-304. PubMed ID: 28987868
[TBL] [Abstract][Full Text] [Related]
4. CMZ reversed chronic ethanol-induced disturbance of PPAR-α possibly by suppressing oxidative stress and PGC-1α acetylation, and activating the MAPK and GSK3β pathway.
Zeng T; Zhang CL; Song FY; Zhao XL; Xie KQ
PLoS One; 2014; 9(6):e98658. PubMed ID: 24892905
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice.
Lu Y; Zhuge J; Wang X; Bai J; Cederbaum AI
Hepatology; 2008 May; 47(5):1483-94. PubMed ID: 18393316
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytochrome P4502E1 by chlormethiazole attenuated acute ethanol-induced fatty liver.
Chen YY; Zhang CL; Zhao XL; Xie KQ; Zeng T
Chem Biol Interact; 2014 Oct; 222():18-26. PubMed ID: 25162931
[TBL] [Abstract][Full Text] [Related]
7. Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro.
Mahli A; Thasler WE; Patsenker E; Müller S; Stickel F; Müller M; Seitz HK; Cederbaum AI; Hellerbrand C
Oncotarget; 2015 Dec; 6(39):41464-78. PubMed ID: 26497211
[TBL] [Abstract][Full Text] [Related]
8. Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liver.
Gopal T; Kumar N; Perriotte-Olson C; Casey CA; Donohue TM; Harris EN; Talmon G; Kabanov AV; Saraswathi V
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G428-G438. PubMed ID: 31928222
[TBL] [Abstract][Full Text] [Related]
9. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
[No Abstract] [Full Text] [Related]
10. Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans.
Xu MJ; Cai Y; Wang H; Altamirano J; Chang B; Bertola A; Odena G; Lu J; Tanaka N; Matsusue K; Matsubara T; Mukhopadhyay P; Kimura S; Pacher P; Gonzalez FJ; Bataller R; Gao B
Gastroenterology; 2015 Oct; 149(4):1030-41.e6. PubMed ID: 26099526
[TBL] [Abstract][Full Text] [Related]
11. The induction of cytochrome P450 2E1 by ethanol leads to the loss of synaptic proteins via PPARα down-regulation.
Na S; Li J; Zhang H; Li Y; Yang Z; Zhong Y; Dong G; Yang J; Yue J
Toxicology; 2017 Jun; 385():18-27. PubMed ID: 28385499
[TBL] [Abstract][Full Text] [Related]
12. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
13. Methyl ferulic acid attenuates ethanol-induced hepatic steatosis by regulating AMPK and FoxO1 Pathways in Rats and L-02 cells.
Cheng Q; Li YW; Yang CF; Zhong YJ; He H; Zhu FC; Li L
Chem Biol Interact; 2018 Aug; 291():180-189. PubMed ID: 29940154
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of ethanol on Sestrin3 in the pathogenesis of ethanol-induced liver injury.
Kang X; Petyaykina K; Tao R; Xiong X; Dong XC; Liangpunsakul S
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(1):G58-65. PubMed ID: 24833709
[TBL] [Abstract][Full Text] [Related]
15. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.
Pritchard MT; McMullen MR; Stavitsky AB; Cohen JI; Lin F; Edward Medof M; Nagy LE
Gastroenterology; 2007 Mar; 132(3):1117-1126. PubMed ID: 17383432
[TBL] [Abstract][Full Text] [Related]
16. Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice.
Kong L; Ren W; Li W; Zhao S; Mi H; Wang R; Zhang Y; Wu W; Nan Y; Yu J
Lipids Health Dis; 2011 Dec; 10():246. PubMed ID: 22208561
[TBL] [Abstract][Full Text] [Related]
17. Zeaxanthin dipalmitate therapeutically improves hepatic functions in an alcoholic fatty liver disease model through modulating MAPK pathway.
Xiao J; Wang J; Xing F; Han T; Jiao R; Liong EC; Fung ML; So KF; Tipoe GL
PLoS One; 2014; 9(4):e95214. PubMed ID: 24740309
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
[TBL] [Abstract][Full Text] [Related]
19. Role of CYP2E1 in ethanol-induced oxidant stress, fatty liver and hepatotoxicity.
Cederbaum AI
Dig Dis; 2010; 28(6):802-11. PubMed ID: 21525766
[TBL] [Abstract][Full Text] [Related]
20. Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease.
Wang Z; Yao T; Song Z
J Lipid Res; 2010 Nov; 51(11):3158-65. PubMed ID: 20739640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
